Effect of Vitamin D Supplementation on Blood Pressure and HbA1c Levels in Patients With T2D

Phase 3

Completed

• Conditions: Diabetes Mellitus Type 2
• Interventions: Drug: 25(OH) vitamin D; Drug: 0.9 % NaCl

• Registration Number: NCT01585051
• Lead Sponsor: Kantonsspital Baselland Bruderholz

Brief Summary

The effect of administration of vitamin D is tested on the long-term control of blood sugar (as measured by HbA1-c levels in blood) and mean blood pressure (as measured by 24 hour blood pressure profiles)in patients with stable type 2 diabetes mellitus

Detailed Description

Not available

Study Timeline

• Study Start: 2009-01
• Primary Completion: 2010-06
• Study Completion: 2010-06
• Status Verified: 2012-04
• Study First Submitted: 2012-04-23
• Study First Submitted QC: 2012-04-24
• Last Update Submitted: 2012-04-24
• Study First Posted: 2012-04-25
• Last Update Posted: 2012-04-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
vitamin D	25(OH) vitamin D	Intervention: Intramuscular injection of 300 000 U of 25(OH)vitamin D
placebo	0.9 % NaCl	administration of 0.9 % NaCl as a placebo

Primary Outcome Measures

Name	Time	Method
Change in HBA1-c levels	3 and 6 months
24 hour mean blood pressure	3 and 6 months

Secondary Outcome Measures

Name	Time	Method
plasma glucose	3 and 6 months
HOMA	6 months

Trial Locations

Locations (1)

Department of medicine, Kantonsspital Bruderholz; 🇨🇭 Bruderholz/Basel, Basel-Landschaft, Switzerland